Immediate Impact
1 from Science/Nature 58 standout
Citing Papers
EASL Clinical Practice Guidelines on the management of hepatitis B virus infection
2025 Standout
Hepatitis C Guidance 2023 Update: American Association for the Study of Liver Diseases– Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection
2023 Standout
Works of Nan Hou being referenced
A randomised study of peginterferon and ribavirin for 16 versus 24 weeks in patients with genotype 2 chronic hepatitis C
2006
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Nan Hou | 258 | 273 | 1 | 37 | 7 | 293 | |
| Pascale Aumont | 256 | 284 | 36 | 6 | 296 | ||
| Helen White | 117 | 128 | 57 | 8 | 225 | ||
| Maud Blanluet | 126 | 142 | 33 | 8 | 164 | ||
| M. El‐Hoseiny | 217 | 249 | 1 | 34 | 8 | 285 | |
| Leonie Grellier | 126 | 140 | 24 | 6 | 182 | ||
| Sabrina Ghetti | 205 | 242 | 49 | 10 | 308 | ||
| J L Payen | 214 | 253 | 34 | 8 | 315 | ||
| T. Gerlach | 180 | 235 | 1 | 35 | 12 | 298 | |
| Carola Mix | 282 | 297 | 20 | 13 | 314 | ||
| J.T. Brouwer | 191 | 223 | 38 | 13 | 275 |
All Works
Login with ORCID to disown or claim papers
Loading papers...